PE123899A1 - Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico - Google Patents

Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico

Info

Publication number
PE123899A1
PE123899A1 PE00102998A PE00102998A PE123899A1 PE 123899 A1 PE123899 A1 PE 123899A1 PE 00102998 A PE00102998 A PE 00102998A PE 00102998 A PE00102998 A PE 00102998A PE 123899 A1 PE123899 A1 PE 123899A1
Authority
PE
Peru
Prior art keywords
alpha
opioid
adrenergic agonist
formulation containing
analgesic
Prior art date
Application number
PE00102998A
Other languages
English (en)
Spanish (es)
Inventor
Johannes Schneider
Johannes Bartholomaus
Johanna Korioth
Jurgen Betzing
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE123899A1 publication Critical patent/PE123899A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE00102998A 1997-11-11 1998-11-02 Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico PE123899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1997149724 DE19749724A1 (de) 1997-11-11 1997-11-11 Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln

Publications (1)

Publication Number Publication Date
PE123899A1 true PE123899A1 (es) 1999-12-25

Family

ID=7848237

Family Applications (1)

Application Number Title Priority Date Filing Date
PE00102998A PE123899A1 (es) 1997-11-11 1998-11-02 Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico

Country Status (5)

Country Link
AU (1) AU1665499A (de)
DE (2) DE19749724A1 (de)
PE (1) PE123899A1 (de)
WO (1) WO1999024023A2 (de)
ZA (1) ZA9810272B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091181B2 (en) 1994-12-12 2006-08-15 Omeros Corporation Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
WO2000023066A2 (en) * 1998-10-20 2000-04-27 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
US20030087962A1 (en) 1998-10-20 2003-05-08 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
PE20001396A1 (es) * 1999-01-18 2000-12-23 Gruenenthal Chemie Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
US6572891B1 (en) 1999-10-23 2003-06-03 Alkaloid Ad Sublingual oral dosage form
AU7023200A (en) * 1999-10-23 2001-05-08 Alkaloid Ad Oral dosage form comprising a salt of morphine or a morphine derivative
CA2627158A1 (en) * 2005-08-30 2007-03-08 Queen's University At Kingston Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to an opioid receptoi agonists using an ultralow dose of an alpha-2receptor antagonist
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
AU2008216867B2 (en) * 2007-02-09 2014-01-30 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
CA2858721C (en) 2011-12-11 2021-03-16 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
TR201815935T4 (tr) 2012-05-02 2018-11-21 Orexo Ab Akut ağrının tedavisi için yeni alfentanil bileşimi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation

Also Published As

Publication number Publication date
DE19758564A1 (de) 1999-08-26
ZA9810272B (en) 1999-05-10
WO1999024023A2 (de) 1999-05-20
DE19749724A1 (de) 1999-06-10
AU1665499A (en) 1999-05-31
WO1999024023A3 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
UA41316C2 (uk) Трициклічні похідні піролу і фармацевтичний препарат
BR0107869A (pt) Composições farmacêuticas eletrogiradas
CA2260943A1 (en) Formulation of 5-ht agonists
HUP0204163A2 (hu) Opioid agonistát és antagonistát tartalmazó szabályozott leadású készítmény és eljárás az előállítására
KR900701252A (ko) 코로 투약하는 벤조디아제핀 최면제
HU1500214D0 (hu) Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
WO1999024023A3 (de) FORMULIERUNG EINER KOMBINATION AUS OPIOID UND α-ADRENERGEM AGONISTEN UND DEREN VERWENDUNG
TNSN01053A1 (fr) Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
CO5640086A2 (es) Formulacion agonistas opioide con antagonistas liberables y secuestrados
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
GB2335357A (en) Chitosan-gelatin A microparticles
AU7315301A (en) Compounds and compositions for delivering active agents
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
BR9810729A (pt) Composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsionante
CA2325739A1 (en) Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a nmda receptor complex modulator
WO2001085150A3 (en) Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
ES2189252T3 (es) Composiciones analgesicas que comprenden un antagonista de la colecistoquinina y un opioide.
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
FI962369A7 (fi) Farmaseuttinen formulointi myrkytyksen ehkäisemiseksi tai esihoidoksi organofosforisilla koliiniesteraasi-inhibiittoreilla

Legal Events

Date Code Title Description
FC Refusal